Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermot Ryan

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
NPJ Primary Care Respiratory Medicine|March 24, 2017
Personalising care of adults with asthma from Asia: a modified e-Delphi consensus study to inform management tailored to attitude and control profilesAlison Chisholm, David B Price, Hilary Pinnock, et al.
NPJ Primary Care Respiratory Medicine|January 6, 2017
Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profilesAlison Chisholm, David B Price, Hilary Pinnock, et al.
The World Allergy Organization Journal|December 30, 2020
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary careHilda J I De Jong, Jaco Voorham, Glenis K Scadding, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Therapeutic Advances in Respiratory Disease|April 30, 2025
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatmentIris van Geer-Postmus, Marika T Leving, Yoran H Gerritsma, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Chest|December 13, 2024
Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma CareMilos Jesenak, Anna Bobcakova, Ratko Djukanovic, et al.
NPJ Primary Care Respiratory Medicine|December 6, 2019
A multinational observational study identifying primary care patients at risk of overestimation of asthma controlVicky Kritikos, David Price, Alberto Papi, et al.
Journal of Asthma and Allergy|October 29, 2020
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care PatientsVicky Kritikos, David Price, Alberto Papi, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
NPJ Primary Care Respiratory Medicine|March 24, 2017
Personalising care of adults with asthma from Asia: a modified e-Delphi consensus study to inform management tailored to attitude and control profilesAlison Chisholm, David B Price, Hilary Pinnock, et al.
NPJ Primary Care Respiratory Medicine|January 6, 2017
Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profilesAlison Chisholm, David B Price, Hilary Pinnock, et al.
The World Allergy Organization Journal|December 30, 2020
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary careHilda J I De Jong, Jaco Voorham, Glenis K Scadding, et al.
Expert Opinion on Pharmacotherapy|March 10, 2015
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gapsJean Bousquet, Claus Bachert, Jonathan Bernstein, et al.
Therapeutic Advances in Respiratory Disease|April 30, 2025
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatmentIris van Geer-Postmus, Marika T Leving, Yoran H Gerritsma, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Chest|December 13, 2024
Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma CareMilos Jesenak, Anna Bobcakova, Ratko Djukanovic, et al.
NPJ Primary Care Respiratory Medicine|December 6, 2019
A multinational observational study identifying primary care patients at risk of overestimation of asthma controlVicky Kritikos, David Price, Alberto Papi, et al.
Journal of Asthma and Allergy|October 29, 2020
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care PatientsVicky Kritikos, David Price, Alberto Papi, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Pageof 13